Sabra Healthcare REIT closed at $21.09 on Nov 4, up 3.64%, 5.8% below its 52-week closing high. Volume of 5.5M shares was 2.36× its 20-day average (well above normal).
Split-adjusted performance: +10.3% over one month, +2.9% over six months, +17.9% over one year.
In the quarter ended Sep 30, 2026, revenue was $246.34M, up 38.9% from a year earlier, with a net margin of 11.6%.
Short interest was 17.7M shares at the Oct 15 settlement, down 11.1% from the prior report (7.0% of float, 7.2 days to cover).